Amylase
Enzyme Preparations
- Drug class
- Enzyme Preparations
- Availability
- See label
- Markets covered
- 1
- Products on record
- 3
Overview
Amylase is an active pharmaceutical ingredient in the Enzyme Preparations group (A09AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 3 | May 29, 2026 |
GBUnited Kingdom· MHRA
3 products
Uses
Pancrex V is used to compensate for reduced intestinal enzyme activity in pancreatic deficiency states. It is indicated for the treatment of fibrocystic disease of the pancreas (cystic fibrosis), chronic pancreatitis and pancreatic steatorrhoea following pancreatectomy.
It may also be indicated following gastrectomy as an aid to digestion.
How to take
Sources & citations
- [1]MHRA (UK) · PL410940006 · revised July 18, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.